Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Olubukola T. Idoko
Observed names:
Idoko, Olubukola T.,
O. T. Idoko,
O.T. Idoko,
Olubukola Idoko,
Olubukola T Idoko
Institutions:
Boston Children's Hospital,
Sanofi (France),
London School of Hygiene & Tropical Medicine,
MRC Unit the Gambia,
Medical Research Council
Observed institutions:
Boston Children's Hospital,
Sanofi (France),
London School of Hygiene & Tropical Medicine,
MRC Unit the Gambia,
Jos University Teaching Hospital,
Ludwig-Maximilians-Universität München,
Medical Research Council
show all 7
ORCID:
0000-0002-8802-2946
Observed ORCID:
0000-0002-8802-2946
OpenAlex ID:
A5000582936
Dynamic molecular changes during the first week of human life follow a robust developmental trajectory
2019
·
Amy H. Lee
, Casey P. Shannon
, et al.
·
Nature Communications
·
188
PDF
Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans
2011
·
Samba O. Sow
, Brown J. Okoko
, et al.
·
New England Journal of Medicine
·
178
PDF
BCG vaccination–induced emergency granulopoiesis provides rapid protection from neonatal sepsis
2020
·
Byron Brook
, Danny J. Harbeson
, et al.
·
Science Translational Medicine
·
126
Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study
2017
·
Aderonke Odutola
, Martin O.C. Ota
, et al.
·
Vaccine
·
75
PDF
Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: An open-label randomized controlled trial
2014
·
Olubukola T. Idoko
, Olumuyiwa A. Owolabi
, et al.
·
Tuberculosis
·
64
Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia
2015
·
Anna Roca
, Abdoulie Bojang
, et al.
·
Vaccine
·
56
PDF
A scorecard of progress towards measles elimination in 15 west African countries, 2001–19: a retrospective, multicountry analysis of national immunisation coverage and surveillance data
2021
·
Oghenebrume Wariri
, Esin Nkereuwem
, et al.
·
The Lancet Global Health
·
48
PDF
Tracking coverage, dropout and multidimensional equity gaps in immunisation systems in West Africa, 2000–2017
2019
·
Oghenebrume Wariri
, Bassey Edem
, et al.
·
BMJ Global Health
·
45
PDF
Preparing for Life: Plasma Proteome Changes and Immune System Development During the First Week of Human Life
2020
·
Tue Bjerg Bennike
, Benoit Fatou
, et al.
·
Frontiers in Immunology
·
34
PDF
Zika Virus in West Africa: A Seroepidemiological Study between 2007 and 2012
2020
·
Serena Marchi
, Simonetta Viviani
, et al.
·
Viruses
·
33
PDF
Towards Precision Vaccines: Lessons From the Second International Precision Vaccines Conference
2020
·
Dheeraj Soni
, Simon D. Van Haren
, et al.
·
Frontiers in Immunology
·
32
PDF
Bacille Calmette-Guérin vaccine reprograms human neonatal lipid metabolism in vivo and in vitro
2022
·
Joann Diray-Arce
, Asimenia Angelidou
, et al.
·
Cell Reports
·
31
PDF
Antibody kinetics following vaccination with MenAfriVac: an analysis of serological data from randomised trials
2019
·
Michael White
, Olubukola Idoko
, et al.
·
The Lancet Infectious Diseases
·
30
PDF
Impact, Challenges, and Future Projections of Vaccine Trials in Africa
2013
·
Olubukola T. Idoko
, Sonali Kochhar
, et al.
·
American Journal of Tropical Medicine and Hygiene
·
27
The burden of viral respiratory infections in young children in low-resource settings
2020
·
Uduak Okomo
, Olubukola T Idoko
, et al.
·
The Lancet Global Health
·
24
PDF
Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2–29 Years
2015
·
Aldiouma Diallo
, Samba O. Sow
, et al.
·
Clinical Infectious Diseases
·
23
PDF
Willingness of Nigerian Healthcare Workers to Donate Kidneys
2008
·
E. I. Agaba
, I. E. Ocheke
, et al.
·
The International Journal of Artificial Organs
·
23
Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea
2020
·
Olubukola T. Idoko
, Kinga K. Smolen
, et al.
·
Frontiers in Pediatrics
·
22
PDF
Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines – A phase II, randomised, observer-blind study in Gambian infants
2019
·
Aderonke Odutola
, Martin O.C. Ota
, et al.
·
Vaccine
·
22
PDF
Community Perspectives Associated With the African PsA-TT (MenAfriVac) Vaccine Trials
2015
·
Olubukola T. Idoko
, Aldiouma Diallo
, et al.
·
Clinical Infectious Diseases
·
19
PDF
Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa
2008
·
Brown J. Okoko
, Olubukola T. Idoko
, et al.
·
Vaccine
·
18
Antibody Persistence 1–5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12–23 Months of Age
2015
·
Milagritos D. Tapia
, Helen Findlow
, et al.
·
Clinical Infectious Diseases
·
17
PDF
Increased Disease due to Haemophilus influenzae Type b
2015
·
Grant A. Mackenzie
, Usman N.A. Ikumapayi
, et al.
·
The Pediatric Infectious Disease Journal
·
17
Lessons in participant retention in the course of a randomized controlled clinical trial
2014
·
Olubukola T Idoko
, Olumuyiwa A Owolabi
, et al.
·
BMC Research Notes
·
17
PDF
Conducting clinical research in a resource-constrained setting: lessons from a longitudinal cohort study in The Gambia
2021
·
Abdulazeez Imam
, Oghenebrume Wariri
, et al.
·
BMJ Global Health
·
16
PDF
Show more works
View as search
Works count:
74
Citation count:
1,445
H-index:
19
I10-index:
42
Year
Topic
Type